Literature DB >> 14963068

Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).

Jae-Hoon Song1, Hyun-Ha Chang, Ji Yoeun Suh, Kwan Soo Ko, Sook-In Jung, Won Sup Oh, Kyong Ran Peck, Nam Yong Lee, Yonghong Yang, Anan Chongthaleong, Nalinee Aswapokee, Cheng-Hsun Chiu, M K Lalitha, Jennifer Perera, Ti Teow Yee, Gamini Kumararasinghe, Farida Jamal, Adeeba Kamarulazaman, Navaratnam Parasakthi, Pham Hung Van, Thomas So, Tak Keung Ng.   

Abstract

OBJECTIVES: To characterize mechanisms of macrolide resistance among Streptococcus pneumoniae from 10 Asian countries during 1998-2001.
METHODS: Phenotypic and genotypic characterization of the isolates and their resistance mechanisms.
RESULTS: Of 555 isolates studied, 216 (38.9%) were susceptible, 10 (1.8%) were intermediate and 329 (59.3%) were resistant to erythromycin. Vietnam had the highest prevalence of erythromycin resistance (88.3%), followed by Taiwan (87.2%), Korea (85.1%), Hong Kong (76.5%) and China (75.6%). Ribosomal methylation encoded by erm(B) was the most common mechanism of erythromycin resistance in China, Taiwan, Sri Lanka and Korea. In Hong Kong, Singapore, Thailand and Malaysia, efflux encoded by mef(A) was the more common in erythromycin-resistant isolates. In most Asian countries except Hong Kong, Malaysia and Singapore, erm(B) was found in >50% of pneumococcal isolates either alone or in combination with mef(A). The level of erythromycin resistance among pneumococcal isolates in most Asian countries except Thailand and India was very high with MIC(90)s of >128 mg/L. Molecular epidemiological studies suggest the horizontal transfer of the erm(B) gene and clonal dissemination of resistant strains in the Asian region.
CONCLUSION: Data confirm that macrolide resistance in pneumococci is a serious problem in many Asian countries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963068     DOI: 10.1093/jac/dkh118

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  31 in total

1.  Emergence of a unique multiply-antibiotic-resistant Streptococcus pneumoniae serotype 7B clone in Dhaka, Bangladesh.

Authors:  Mahbubur Rahman; Shahadat Hossain; Shereen Shoma; Harunur Rashid; Abdullah Hel Baqui; Mark van der Linden; Adnan Al-Lahham; Ralf René Reinert
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

2.  The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271.

Authors:  Maria Del Grosso; John G E Northwood; David J Farrell; Annalisa Pantosti
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

Review 3.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 4.  Elderly patients with community-acquired pneumonia: optimal treatment strategies.

Authors:  Ulrich Thiem; Hans-Jürgen Heppner; Ludger Pientka
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

5.  Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study.

Authors:  So Hyun Kim; Jae-Hoon Song; Doo Ryeon Chung; Visanu Thamlikitkul; Yonghong Yang; Hui Wang; Min Lu; Thomas Man-Kit So; Po-Ren Hsueh; Rohani M Yasin; Celia C Carlos; Hung Van Pham; M K Lalitha; Nobuyuki Shimono; Jennifer Perera; Atef M Shibl; Jin Yang Baek; Cheol-In Kang; Kwan Soo Ko; Kyong Ran Peck
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

Review 6.  Resistance to Macrolide Antibiotics in Public Health Pathogens.

Authors:  Corey Fyfe; Trudy H Grossman; Kathy Kerstein; Joyce Sutcliffe
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

7.  Bacterial resistance surveillance in China: a report from Mohnarin 2004-2005.

Authors:  Y H Xiao; J Wang; Y Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-19       Impact factor: 3.267

8.  Serogroup distribution and antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae among Beijing children with upper respiratory infections (2000-2005).

Authors:  S Yu; K Yao; X Shen; W Zhang; X Liu; Y Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-18       Impact factor: 3.267

9.  High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study).

Authors:  Jae-Hoon Song; Sook-In Jung; Kwan Soo Ko; Na Young Kim; Jun Seong Son; Hyun-Ha Chang; Hyun Kyun Ki; Won Sup Oh; Ji Yoeun Suh; Kyong Ran Peck; Nam Yong Lee; Yonghong Yang; Quan Lu; Anan Chongthaleong; Cheng-Hsun Chiu; M K Lalitha; Jennifer Perera; Ti Teow Yee; Gamini Kumarasinghe; Farida Jamal; Adeeba Kamarulzaman; Navaratnam Parasakthi; Pham Hung Van; Celia Carlos; Thomas So; Tak Keung Ng; Atef Shibl
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Macrolide combination antibiotic therapy should be prudently considered in complicated CAP cases and in regions with low macrolide susceptibility.

Authors:  Hsin-I Shih; Hsiang-Chin Hsu; Chih-Hsien Chi; Wen-Chien Ko
Journal:  Intensive Care Med       Date:  2010-07-15       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.